Analgesics recorded 8% value growth in 2014, higher than the 6% value CAGR witnessed over the review period. The category is expected to enter the maturity phase from 2016 onwards, although in 2015 it recorded healthy growth due to the growing population and tourist flows into the country.
GlaxoSmithKline led analgesics with a 33% value share in 2015 followed by Julphar Gulf Pharmaceuticals with 8% and Abbott Laboratories with a 5% value share. GlaxoSmithKline remained the strongest player in analgesics due to the strong image of its Panadol range in the United Arab Emirates. Julphar Gulf Pharmaceuticals is the leading domestic company producing generic drugs, such as paracetamol, and its popular Adol version. Abbott Laboratories benefited from the immense popularity of its Brufen, which is a brand name synonymous with ibuprofen in every household in the United Arab Emirates.
Full Report Details at
Analgesics is increasingly entering maturity and therefore growth rates are expected to slow over the forecast period. A value CAGR of 4% at constant 2015 prices is expected over the forecast period compared to the 5% constant value CAGR recorded over the review period. Within adult analgesics, adult ibuprofen is set to lead in terms of growth with a value CAGR of 5% constant 2015 prices over the forecast period, followed by adult acetaminophen with a constant value CAGR of 4%. This will be in line with the popularity of the international brands of these drugs, and will also be influenced by consumer consumption patterns as they opt to take these medicines during pain and fever due to their familiarity with them.
Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in United Arab Emirates with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Analgesics industry in United Arab Emirates, our research will save you time and money while empowering you to make informed, profitable decisions.
The Analgesics in United Arab Emirates market research report includes:
* Analysis of key supply-side and demand trends
* Detailed segmentation of international and local products
* Historic volumes and values, company and brand market shares
* Five year forecasts of market trends and market growth
* Robust and transparent market research methodology, conducted in-country
Our market research reports answer questions such as:
* What is the market size of Analgesics in United Arab Emirates?
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.
For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)
You may also be interested in these related reports:
- Healthcare Providers in United Arab Emirates
- Consumer Health in the United Arab Emirates
- The Future of the Savory and Deli Foods Market in the United Arab Emirates to 2019
- The Future of the Ice Cream Market in the United Arab Emirates to 2019
- The Future of the Confectionery Market in the United Arab Emirates to 2019
"Analgesics in the United Arab Emirates" now available at Fast Market Research
Contact Name: Bill Thompson
Contact Email: firstname.lastname@example.org
Contact Phone: 1-413-485-7001